Proposed LCD DL39857: Botulinum Toxin Injections — CGS
Policy LCD-DL39857 · Pain Management
Impact on botulinum toxin injection billing proposed.
Code intelligence
Policy changes, MAC LCD updates, and CMS guidance matched to code J0586.
Signal breakdown
21 shown · 21 total in platform
Critical
10%
High
62%
Routine
29%
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Policy LCD-DL39857 · Pain Management
Impact on botulinum toxin injection billing proposed.
Policy FR-2026-13656 · Hospital Outpatient (OPPS)
CY2027 OPPS/ASC proposed rule expands prior auth for Botulinum Toxin.
Policy LCD-L39909 · Pain Management
Prepare for billing changes for botulinum toxin injections.
Policy LCD-L39832 · Pain Management
New LCD on Botulinum Toxin Injections impacts billing.
Policy LCD-L35172 · Pain Management
Important updates for Botulinum Toxin Injection billing.
Policy LCD-L39836 · Pain Management
New LCD for Botulinum Toxin Injections effective 02/22/2026
Policy LCD-L35170 · Pain Management
New guidelines on Botulinum Toxin Injections may alter billing.
Policy LCD-L39857 · Pain Management
New billing guidelines for Botulinum treatments effective 2026.
Policy LCD-DL39909 · Pain Management
New LCD may improve reimbursement for Botox injections.
Policy LCD-DL39836 · Pain Management
Impact of new LCD on botulinum toxin injections reimbursement.
Policy LCD-DL35010 · Pain Management
New LCD on trigger point injections may impact billing.
Policy LCD-DL35172 · Pain Management
New LCD may affect botulinum toxin injection billing.
Policy LCD-DL33912 · Pain Management
New LCD for Trigger Point Injections by First Coast affects billing.
Policy LCD-L33949 · Pain Management
New LCD on Botulinum Toxins effective Feb 2025.
Policy LCD-L33274 · Pain Management
Important billing updates for Botulinum Toxins treatment.
Policy LCD-DL39832 · Multi-specialty
Proposed LCD for Botulinum Toxin Injections requires review.
Policy LCD-L34635 · Pain Management
New LCD on Botulinum Toxin by WPS impacts billing practices.
Policy LCD-L33458 · Pain Management
New LCD on Chemodenervation impacts billing for providers.
Policy LCD-L33646 · Pain Management
Implementing Botulinum Toxins LCD may affect billing practices.
Policy LCD-DL33274 · Pain Management
New LCD for Botulinum Toxins affects billing and reimbursements.
Policy LCD-L38809 · Pain Management
Prepare for Novitas' LCD on Botulinum Toxins effective 11/09/2025.
Audit documentation
The Tripwire Audit Pack exports 12 months of Pain Management policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.